Plain-English translation of NCT04952870 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers are concerned that COVID-19 infection in newborns may affect the development of hormones that control growth and development during infancy—a critical window called "minipuberty." This observational study compares newborns exposed to COVID-19 with newborns who received a breathing treatment called inhaled nitric oxide and healthy newborns, to see whether the virus changes how these important hormones develop and whether this affects health later in life.
COVID-19 may affect the pituitary gland (which controls many hormones in the body), and early hormone changes could lead to health problems later. By studying newborns during this critical time, researchers hope to understand whether and how the virus causes these changes, which could help prevent long-term complications.
You likely qualify if…
You likely don't qualify if…
This is an observational study, meaning researchers will not give your baby any new treatment—they will simply follow and compare your baby's medical records and test results over time. You will be enrolled at a hospital in Lille, France, and researchers will collect information about your baby's health, development, and hormone levels during routine hospital care or follow-up visits. There is no medication or invasive procedure required beyond normal newborn screening and care.
AI-generated summary from trial data · Jun 6, 2026 · Not medical advice
France
Greece